Search results for: 'alzheimer'
- A1124 Amyloid Beta-Peptide (1-40) (human)1 CitationSummary: residues 1-40 of human amyloid-beta
- A1038 Amyloid β-Peptide (10-20) (human)Summary: Initiates neurodegeneration in Alzheimer disease
- A8465 LY28867211 CitationTarget: BACESummary: BACE inhibitor
- A8515 Rivastigmine TartrateSummary: AChR inhibitor
- A1039 Amyloid Beta-peptide (25-35) (human)1 CitationSummary: Functional domain of Aβ
- BA8516 CAD031Summary: CAD031 is a derivative of the Alzheimer's disease (AD)-targeting agent J147 with neuroprotective and memory-enhancing properties.
- B1572 LatrepirdineTarget: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptorSummary: Brain cell death inhibitor
- C8646 β-Amyloid (1-16)Summary: β-Amyloid (1-16) is a metal-binding peptide fragment derived from β-amyloid, associated with Alzheimer's disease pathology.
- BA8426 OAB-14Summary: OAB-14, a Bexarotene derivative, ameliorates Alzheimer's disease-associated pathology and cognitive deficits by increasing beta-amyloid clearance in APP/PS1 mice.
- BA8408 AzeliragonSummary: Azeliragon (TTP488) is a bioavailable late-stage glycosylation end product receptor inhibitor that mitigates the progression of mild Alzheimer's disease (AD).